Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Viroj Wiwanitkit

doi:10.5681/bi.2013.033

Bioimpacts. 2013;3(4): 199-200.
doi: 10.5681/bi.2013.033

PMID: 24455484
PMCID: PMC3892740
Scopus ID: 84893385121

Abstract View: 1086

PDF Download: 650

Commentary

Commentary on: Serum Albumin for Tuberculosis in HIV Infected Patients Eligible for Antiretroviral Therapy

Viroj Wiwanitkit ^1,2,3^*

¹ Hainan Medical University, China
² Faculty of Medicine, University of Nis, Serbia
³ Joseph Ayobabalola University, Nigeria

*Corresponding Author: Email: wviroj@yahoo.com

Abstract

n/a

Keywords: n/a, n/a, n/a

First Name

Last Name

Email Address

Comments

Security code

Generate New Image

Type the code from the image

Abstract View: 1087

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2024	6	3	7	11	12	9	13	16	12	5	10	5
2023	5	7	5	7	7	6	8	3	9	7	3	3
2022	16	10	11	7	10	16	20	15	11	7	11	4
2021	11	13	13	11	14	13	14	18	5	13	17	15
2020	14	14	11	11	21	14	13	10	18	18	19	14
2019	10	12	10	9	18	11	6	13	13	10	3	9
2018	22	12	22	14	12	6	9	19	12	13	7	16
2017	15	23	23	26	15	26	3					17

PDF Download: 650

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2024	5		5	5	5	3	4	6	7	2	3	7
2023	11	4	4	4	6	5	4	3	4	5	1	4
2022	13	10	12	3	2	4	2	2	4	4	5	8
2021	4	4	4	6	8	12	11	17	13	7	14	13
2020	7	5	11	8	7	4	3	1	5	2	2	6
2019	11	12	4	7	7	9	10	10	8	9	7	12
2018	7	11	14	11	11	14	16	11	13	12	3	20
2017	4	6	6	8	6	11	3					7